Adherent-invasive Escherichia coli and Crohnʼs disease
Authors:
- Nicolas BarnichNicolas Barnich
- Arlette Darfeuille-MichaudADArlette Darfeuille-Michaud
- 1 January 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 23 (1) , 16-20
Abstract
The identification of mutations in the nucleotide oligomerization domain 2-encoding gene in patients with Crohn's disease suggests a link between the innate immune response to invasive bacteria and the development of Crohn's disease. Herein, we review reports concerning the association of pathogenic Escherichia coli with the intestinal mucosa of Crohn's disease patients. Adherent-invasive E. coli were isolated from ileal biopsies of 36.4% of patients with ileal Crohn's disease. Adherent-invasive E. coli colonize the intestinal mucosa by adhering to intestinal epithelial cells. They are also true invasive pathogens, able to invade intestinal epithelial cells and to replicate intracellularly. Adherent-invasive E. coli strains replicate extensively into macrophages inducing the secretion of very large amounts of tumor necrosis factor-alpha. Similar pathogenic E. coli strains were recently associated with granulomatous colitis of Boxer dogs. Interestingly, high levels of E. coli outer membrane protein C antibodies are present in 37-55% of Crohn's disease patients and reactivity to outer membrane protein C is associated with increased severity of Crohn's disease. As the infection cycle of adherent-invasive E. coli could depend upon the ability of these pathogenic bacteria to colonize the gastrointestinal tract of genetically predisposed Crohn's disease patients, antibiotics which could eradicate the bacteria, or probiotics which could substitute them in the gastrointestinal tract, could be of therapeutic value in ileal Crohn's disease.Keywords
This publication has 46 references indexed in Scilit:
- Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's diseaseAmerican Journal of Gastroenterology, 2002
- Mucosal flora in inflammatory bowel diseaseGastroenterology, 2002
- Genetically related Escherichia coli strains associated with Crohn's diseaseGut, 2001
- Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's diseaseGastroenterology, 1998
- Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resectionGastroenterology, 1995
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- Double blind, placebo controlled trial of metronidazole in Crohn's disease.Gut, 1991
- Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgeryBritish Journal of Surgery, 1984
- METRONIDAZOLE FOR CROHN'S DISEASEThe Lancet, 1975
- FURTHER ANIMAL EVIDENCE OF A TRANSMISSIBLE AGENT IN CROHN'S DISEASEThe Lancet, 1973